Individual mammalian cells contain billions of protein molecules, which must be synthesized, deployed, and removed with ...

Tabular foundation models are the next major unlock for AI adoption, especially in industries sitting on massive databases of ...

The mainstreaming of AI is turning into a trillion dollar business, yet the two biggest data center real estate firms have ...

The U.S. Senate Banking Committee will not have any markup hearings on market structure legislation defining how federal regulators can oversee the industry until next year, punting on a hoped-for ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Amid an outpouring of obesity data Monday, Wave Life Sciences and Structure Therapeutics were among the biotechs jockeying to set their weight loss assets apart in an increasingly crowded field as ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...

How is AI and data leadership at large organizations being transformed by the accelerating pace of AI adoption? Do these leaders’ mandates need to change? And should overseeing AI and data be viewed ...

A new study found the total value of blocked or delayed data center projects during a three-month stretch earlier this year exceeded the total in the prior two years, signaling accelerating opposition ...

The amount of capital pouring into AI data center projects is staggering. Last week, Microsoft, Alphabet, Meta, and Amazon reported their 2025 capital expenditures would total roughly $370 billion, ...

A controlled test compared three nearly identical pages: one with strong schema, one with poor schema, and one with none. Only the page with well-implemented schema appeared in an AI Overview and ...